CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Confirmation of high SVR rates after shortening duration of treatment with Peginterferon alfa–2a (PEG) and Ribavirin (RBV) in Chronic Hepatitis C (CHC) Patients with RVR in Real Life
DOI 10.1055/s-0031-1295915
Bibliografische Angaben
Nachweis in CareLit
Autor:innenD Hüppe, S Mauss, T Lutz, M Schuchmann, G Moog, A Schober, R Heyne, C John, W Schiffelholz, C Eisenbach, G Teuber, A Baumgarten, E Schott, U Alshuth, P Buggisch
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Studies showed that SVR in patients with low viral load (LVL) is high and treatment duration can be reduced while maintaining high SVR rates. But is this true under real life conditions? Methods: Between 2008 and 2011 data of 3810 patients completing a treatment period of 6 months for GT 2/3 or 12 months for GT 1 plus 6 months follow-up were recorded in a noninterventional study. This analysis included 745 naïve pat…
Zitieren
Zitierempfehlung
D Hüppe, S Mauss, T Lutz, M Schuchmann, G Moog, A Schober, R Heyne, C John, W Schiffelholz, C Eisenbach, G Teuber, A Baumgarten, E Schott, U Alshuth, P Buggisch (2012) Confirmation of high SVR rates after shortening duration of treatment with Peginterferon alfa–2a (PEG) and Ribavirin (RBV) in Chronic Hepatitis C (CHC) Patients with RVR in Real Life. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0031-1295915
Mit CareLit weiterarbeiten